Loading clinical trials...
Loading clinical trials...
The purpose of this study is to enroll participants who present with an adnexal mass on imaging to develop a non-invasive ovarian cancer assay to distinguish between malignant and benign masses. The s...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Natera, Inc.
NCT05761275 · Gynecologic Disease, Adnexal Mass, and more
NCT06638593 · Ovarian Cancer, Ovarian Mass, and more
NCT05974618 · Adnexal Mass, Adnexal Tumor, and more
NCT03297112 · Adnexal Mass
NCT04668521 · Adnexal Mass, Germline BRCA1 Gene Mutation, and more
Magee-Women's Hospital of UPMC
Pittsburgh, Pennsylvania
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions